Thom Busby

Partner

Thom Busby joined Mirus as a Partner in 2025. He has more than a decade of dedicated life science and healthcare investment banking experience, and a twenty-year history of successfully raising capital. Thom has advised dozens of senior management teams on a full range of corporate transactions spanning M&A, divestments, majority/minority recapitalizations, private equity/debt, platform/tuck-in acquisitions, venture capital, strategic build-to-buy investments, partnerships, and bankruptcies.

Thom is sought-after by clients for his strong commitment to their success, strategic and creative approach to transacting, and deep industry knowledge and experience in high-innovation segments including medical device, biopharma, diagnostics, instrumentation and digital health/HCIT. Additionally, Thom has extensive experience in life science service verticals such as CROs, CDMOs, consultancies, laboratories, and other outsourced pharma and medtech providers. A noted expert in his field, Thom is a regular panelist, moderator, writer and podcast guest discussing middle market life science transaction activity and trends.

Thom holds a BA and MBA from Suffolk University where he attended on full academic scholarship. He holds Series 63 & 79 licenses from FINRA. A lifelong New Englander and Mayflower decedent, he lives on the South Shore with his wife, daughter and son where they enjoy time at the beach and entertaining friends and family. When not discussing life science M&A or chasing his two children, Thom enjoys cooking, golf, wine and reading.

Check the background of this investment professional on FINRA’s BrokerCheck.